Year-end Sale % OFF 
Abstract
SummaryInjections of a potent preparation of Thymidine in doses equivalent to at least 20, 47, and 80 μg of Vit. B12 were without effect in producing hematologic improvement in patients with tropical sprue in relapse.The thymidine used in this study was purchased from Nutritional Biochemicals Corporation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
